MRNA

Marina Biotech, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 10/25/2016
Contact Info
  • 17870 Castleton Street
  • Suite 250
  • City of Industry, CA 91748

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000737207
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1983
Employees 1 a/o Jan 01, 2014
Company Officers/Contacts
Joseph Ramelli Interim CEO
Mihir Munsif COO
Larn Hwang Chief Scientific Officer
Company Directors
Vuong Trieu Chairman
Donald A Williams Independent Director, Audit Committee Member
Service Providers
Accounting/Auditing Firm
Wolf & Company, P.C.
99 High Street
Boston, MA, 02110
United States
 
Securities Counsel
Pryor Cashman LLP OTCQX Sponsor
7 Times Square
New York, NY, 10036-6569
United States
 
Investor Relations Firm
HDM|Zoomedia
55 West Wacker Drive
Chicago, IL, 60601
United States
 
Company History
  • Formerly= MDRNA,Inc. until 7-2010
  • Formerly=Nastech Pharmaceutical Co., Inc. until 6-2008
MRNA Security Details
Share Structure
Market Value1 $21,545,131 a/o Mar 23, 2017
Authorized Shares 180,000,000 a/o Nov 16, 2016
Outstanding Shares 89,771,379 a/o Nov 18, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 49,008,367 a/o Nov 16, 2016
Par Value 0.006
Shareholders
Shareholders of Record 94 a/o Nov 16, 2016
Short Selling Data
Short Interest 4,428 (-69.5%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security